At its Sept. 30 investor day, Cigna's team reiterated 2026 financial goals and highlighted a plan to return earnings growth back to its long-term target range of 10%-14% starting in 2027, culminating in adjusted EPS of at least $45 per share by 2030.
Combining with Express Scripts gave Cigna more tools to help clients control their healthcare costs, and we see significant cross-selling opportunities across their respective books of business.
Healthcare reform may remain a recurring political topic until universal, affordable coverage is achieved in the US, and Cigna's stock may experience volatility if scenarios that threaten its prospects gain traction.
|
Metric
|
CI
|
CVS
|
HUM
|
|---|---|---|---|
Price/Earnings (Normalized) | 8.51 | 10.87 | 22.07 |
Price/Book Value | 1.66 | 1.37 | 2.37 |
Price/Sales | 0.25 | 0.26 | 0.32 |
Price/Cash Flow | 7.06 | 7.18 | 16.55 |
|
Metric
|
CI
|
CVS
|
HUM
|
|---|---|---|---|
Quick Ratio | 0.68 | 0.62 | — |
Current Ratio | 0.85 | 0.87 | — |
Interest Coverage | 7.08 | 2.87 | 3.37 |
|
Metric
|
CI
|
CVS
|
HUM
|
|---|---|---|---|
Return on Assets (Normalized) | 5.37% | 3.94% | 3.18% |
Return on Equity (Normalized) | 20.03% | 13.12% | 9.02% |
Return on Invested Capital (Normalized) | 12.89% | 8.09% | 7.08% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc
UNH
| LOCK|j$>G@n | LOCK|Gg#v | $328B | |||
| CVS Health Corp
CVS
| LOCK|?%?qLyp | LOCK|X<v | $109B | |||
| Elevance Health Inc
ELV
| LOCK|&JvljLg | LOCK|@?%^ | $83B | |||
| Humana Inc
HUM
| LOCK|pglZwTm | LOCK|FMVk | $46B | |||
| Centene Corp
CNC
| LOCK|Nmm@#dC | LOCK|rZ | $30B | |||
| Molina Healthcare Inc
MOH
| LOCK|<<FWYw | LOCK|QT>&% | $9B | |||
| Oscar Health Inc Class A
OSCR
| — | LOCK|@% | $9B | |||
| Clover Health Investments Corp Ordinary Shares - Class A
CLOV
| — | LOCK|># | $2B | |||
| Progyny Inc
PGNY
| — | LOCK|>Sz | $2B |
United States